Copyright
©The Author(s) 2021.
World J Radiol. Dec 28, 2021; 13(12): 371-379
Published online Dec 28, 2021. doi: 10.4329/wjr.v13.i12.371
Published online Dec 28, 2021. doi: 10.4329/wjr.v13.i12.371
Table 1 Baseline demographics
| Variable | Summary (n = 65) |
| Median age in years (interquartile range) | 54 (41-63) |
| Median BMI in kg/m2 (interquartile range) | 28 (25.1-32.7) |
| Gender | |
| Male | 38 (58.5%) |
| Female | 27 (41.5%) |
| Clinical symptoms | |
| Lower extremity swelling | 57 (87.7%) |
| Lower extremity pain | 44 (67.7%) |
| Venous stasis ulceration | 7 (10.8%) |
| Varicose veins | 3 (4.6%) |
| Pelvic pain | 2 (3.1%) |
| Symptomatic side | |
| Left | 49 (75.4%) |
| Right | 14 (21.5%) |
| Bilateral | 2 (3.1%) |
| Thrombophilia risk factor | |
| Young age (< 40 yr) | 24 (35.9%) |
| Family history | 12 (18.5%) |
| Unprovoked | 16 (24.6%) |
| VTE provoking factor | |
| Prolonged immobilization | 15 (23.1%) |
| Malignancy | 13 (20.0%) |
| Recent surgery | 5 (7.7%) |
| Trauma | 5 (7.7%) |
| Pregnancy | 7 (14.6%) |
| Hormonal supplement | 4 (6.2%) |
| None | 16 (24.6%) |
Table 2 Procedure details
| Variable | Summary (n = 65) |
| Pre-procedure CIV patency | |
| Stenosis | 47 (72.3%) |
| Occlusion | 16 (24.6%) |
| In-stent thrombosis | 2 (3.1%) |
| Stent location | |
| Left CIV | 50 (76.9%) |
| Right CIV | 11 (16.9%) |
| Bilateral CIV | 4 (6.2%) |
| Stent type | |
| Wallstent | 51 (78.5%) |
| Venovo | 9 (13.8%) |
| Smart | 2 (3.1%) |
| Vici | 3 (4.6%) |
| CIV stent balloon dilation diameter (mm) | |
| 12 | 1 (1.5%) |
| 14 | 14 (21.5%) |
| 16 | 28 (43.1%) |
| 18 | 19 (29.2%) |
| 20 | 3 (4.6%) |
| Additional stented segments | |
| External iliac vein | 54 (83.1%) |
| Common femoral vein | 45 (69.2%) |
| Simultaneous endovascular interventions | |
| Thrombolysis | 25 (38.5%) |
| Thrombectomy | 17 (26.2%) |
| CIV filter retrieval | 3 (4.6%) |
Table 3 Complications by thrombophilia testing
| Thrombophilia work-up (n = 33) | Positive (n = 16) | Negative (n = 17) |
| Clinical success | ||
| Stent patency | 14 (87.5%) | 12 (70.6%) |
| 1 mo | 12 of 13 (92.3%) | 13 of 16 (81.3%) |
| 6 mo | 10 of 12 (83.3%) | 12 of 15 (80%) |
| 12 mo | 7 of 9 (77.8%) | 10 of 13 (76.9%) |
| Stent thrombosis | 2 (12.5%) | 4 (23.5%) |
| Anticoagulated during stent thrombosis | 1 of 2 (50%) | 2 of 4 (50%) |
| Re-intervention rates | 4 (25%) | 6 (35.3%) |
| Number of re-interventions | ||
| 1 | 50% | 67% |
| 2 | 0% | 33% |
| 3 | 25% | 0% |
| 4 | 25% | 0% |
- Citation: Cramer P, Mensah C, DeSancho M, Malhotra A, Winokur R, Kesselman A. Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens. World J Radiol 2021; 13(12): 371-379
- URL: https://www.wjgnet.com/1949-8470/full/v13/i12/371.htm
- DOI: https://dx.doi.org/10.4329/wjr.v13.i12.371
